Related references
Note: Only part of the references are listed.GnRH agonist trigger for women with breast cancer undergoing fertility preservation by aromatase inhibitor/FSH stimulation
Kutluk Oktay et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2010)
GNRH ANTAGONIST/LETROZOLE VERSUS MICRODOSE GNRH AGONIST FLARE PROTOCOL IN POOR RESPONDERS UNDERGOING IN VITRO FERTILIZATION
Robab Davar et al.
TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY (2010)
Letrozole administration during the luteal phase after ovarian stimulation impacts corpus luteum function: a randomized, placebo-controlled trial
Juan A. Garcia-Velasco et al.
FERTILITY AND STERILITY (2009)
Comparison of microdose flare-up and antagonist multiple-dose protocols for poor-responder patients: a randomized study
Aygul Demirol et al.
FERTILITY AND STERILITY (2009)
Use of aromatase inhibitors in poor-responder patients receiving GnRH antagonist protocols
Batuhan Ozmen et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2009)
Aromatase inhibitors for female infertility: a systematic review of the literature
Nikolaos P. Polyzos et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2009)
Management of poor responders: can outcomes be improved with a novel gonadotropin-releasing hormone antagonist/letrozole protocol?
William B. Schoolcraft et al.
FERTILITY AND STERILITY (2008)
Aromatase inhibitors for infertility in polycystic ovary syndrome. The beginning or the end of a new era?
Nikolaos P. Polyzos et al.
FERTILITY AND STERILITY (2008)
Safety of fertility preservation by ovarian stimulation with letrozole and Gonadotropins in patients with breast cancer: A prospective controlled study
Amr A. Azim et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Treatment of unexplained infertility with aromatase inhibitors or clomiphene citrate: A systematic review and meta-analysis.
Nikolaos P. Polyzos et al.
OBSTETRICAL & GYNECOLOGICAL SURVEY (2008)
Luteal phase oestradiol suppression by letrozole: a pilot study in oocyte donors
H. M. Fatemi et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2008)
Cancer and fertility preservation: fertility preservation in breast cancer patients
Theodoros Maltaris et al.
BREAST CANCER RESEARCH (2008)
Relative potencies of anastrozole and letrozole to suppress estradiol in breast cancer patients undergoing ovarian stimulation before in vitro fertilization
Amr A. Azim et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy
Kutluk Oktay et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Survival with aromatase inhibitors and inactivators versus standard hormonal therapy in advanced breast cancer: Meta-analysis
Davide Mauri et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Aromatase inhibitors in ovarian stimulation for IVF/ICSI: a pilot study
Willem M. J. A. Verpoest et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2006)
Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate
Togas Tulandi et al.
FERTILITY AND STERILITY (2006)
The role of aromatase inhibitors in ameliorating deleterious effects of ovarian stimulation on outcome of infertility treatment
MFM Mitwally et al.
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY (2005)
Comparison of a gonadotropin-releasing hormone (GnRH) antagonist and GnRH agonist flare-up regimen in poor responders undergoing ovarian stimulation
S Malmusi et al.
FERTILITY AND STERILITY (2005)
The aromatase inhibitor letrozole increases the concentration of intraovarian androgens and improves in vitro fertilization outcome in low responder patients:: a pilot study
JA Garcia-Velasco et al.
FERTILITY AND STERILITY (2005)
A randomized single-blind controlled trial of letrozole as a low-cost IVF protocol in women with poor ovarian response: a preliminary report
SK Goswami et al.
HUMAN REPRODUCTION (2004)
Share Paper
